Results 261 to 270 of about 88,529 (348)
Vildagliptin and omarigliptin, dipeptidyl peptidase‐4 (DPP‐4) inhibitors, have differential effects on bone cells. Although vildagliptin improved the bone microstructure of high‐fat diet‐fed rats, it was unable to downregulate osteoclastogenesis or the expression of key osteoclast transcripts.
Ratchaneevan Aeimlapa +11 more
wiley +1 more source
Plant-derived food bioactives in bone health: from multi-targeted roles to molecular mechanisms in osteoporosis. [PDF]
Zhang Y +7 more
europepmc +1 more source
First, probiotic strain Lactobacillus zeae N165 with oral antibacterial activity, autoaggregation ability and coaggregation ability was screened through in vitro experiments. Then, in vivo efficacy evaluation was conducted on this strain, and a mouse model was used to verify its ameliorative effect on periodontitis.
Qimeng Liang +5 more
wiley +1 more source
Diminished osteoprotegerin production by gingival fibroblasts from periodontitis patients is associated with their reduced ability to suppress osteoclastogenesis. [PDF]
Nieboga E +15 more
europepmc +1 more source
A High Fat/High Sucrose Diet Alters the Skeletal Response to Adenine-Induced Chronic Kidney Disease in Male Rats. [PDF]
Metzger CE +3 more
europepmc +1 more source
Effects of Micropore Size Distribution in Carbonate Apatite Honeycomb Granules on Bone Replacement
Bone regeneration capacity of two carbonate apatite honeycombs with identical porosity but different pore size distributions. ABSTRACT Successful bone defect repair requires understanding both the role of micropores smaller than 10 μm and that of macropores.
Koichiro Hayashi +2 more
wiley +1 more source
Rgnef regulates bone mass through the activation of RhoA and Rac1. [PDF]
Lee J +7 more
europepmc +1 more source
ABSTRACT Background Myeloma bone disease (MBD) is a devastating complication of multiple myeloma (MM) and a primary cause of disability in affected patients. Its pathogenesis is driven by an imbalance in bone remodeling, largely attributed to the overexpression of C‐C motif chemokine ligand 3 (CCL3). While both bortezomib and statins have been reported
Fujun Qu +6 more
wiley +1 more source

